FDA Inspection 988721 — Ari-Med Pharmaceuticals

Ari-Med Pharmaceuticals — FEI 2027206

The FDA completed an inspection of Ari-Med Pharmaceuticals on August 17, 2016 in Tempe, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 17, 2016
Fiscal Year
2016
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Tempe, AZ (United States)

Citations

IDCFRDescription
141321 CFR 211.42(c)(5)Mfg / Processing Operations Area
434221 CFR 211.142(b)Storage under appropriate conditions